How the government shutdown is affecting biotech companies

The government shutdown is affecting the U.S. Food and Drug Administration’s ability to review new drugs, putting biotech companies in a tough spot.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.